When Anna Gallo fell ill, she initially suspected food poisoning — but then she developed more alarming symptoms ...

March 20, 2026 PDUFA goal date for sNDA for setmelanotide in acquired hypothalamic obesity -- BOSTON, March 01, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global ...

Eli Lilly and Company has reported detailed findings from the ACHIEVE-3 Phase III trial comparing the efficacy and safety of ...

The Texan made the mistake of his life when he ordered gummies to soothe symptoms of Crohn’s disease. Now his health is suffering in a foreign jail ...

Japan now offers ELEVIDYS gene therapy to children with Duchenne muscular dystrophy aged 3 years to less than 8 years- Company is eligible to receive a $40 million milestone payment upon first ...

Orforglipron carried more side effects, however ...

TAIPEI (Taiwan News) — Taiwan health authorities are warning of a continuing norovirus outbreak after more than 80,000 people sought medical attention for diarrhea during this year’s Lunar New Year ...

The BRAFTOVI combination regimen is the only approved targeted regimen for first-line BRAF-V600E mutant metastatic colorectal cancerPivotal results from the Phase 3 portion with mFOLFOX6 of the ...

Siegfried is once again called to treat Miss Stokes' guest Hilda as Christmas approaches, bringing a surprise guest.

Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has granted full approval to BRAFTOVI® (encorafenib) in ...

Pratteln, Switzerland, February 27, 2026 – Santhera Pharmaceuticals (SIX: SANN) today announces that the Spanish Interministerial Commission on Prices of Medicines, has proposed to include AGAMREE® ...